According to the new market research report In Vitro Toxicology Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.
Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065
The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.
Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast period
The APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period. Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety are some of the key factors driving the growth of the market in the APAC.
In the toxicity endpoints and tests market, the organ toxicity segment is expected to grow at the highest CAGR during the forecast period
The organ toxicity segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.
Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing market
The cell culture technologies segment is estimated to account for the largest market share in 2018. The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.
By product and service, the consumables segment is expected to account for the largest share of the in vitro toxicology testing market
The consumables segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065
The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).
The In-Vitro Toxicology Testing Market 2021 research report gives emerging industry data, global segments and regional outlook.
This report covers up all details such as size, share, value, growth, restraints, and opportunities for the year 2020 to 2027.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the In-Vitro Toxicology Testing market include Agilent Technologies, Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Charles River, Thermo Fisher Scientific Inc., Catalent, Inc., Eurofins Scientific, GE Healthcare, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, HD Biosciences Co., Ltd.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global In-Vitro Toxicology Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/in-vitro-toxicology-testing-market/download-sample Market DynamicsThe growing popularity of the cost-effective In vitro toxicity testing method because of faster test results than toxicology studies in living animals is the main driver for this growth.
According to the new market research report In Vitro Toxicology Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.By product and service, the consumables segment is expected to account for the largest share of the in vitro toxicology testing marketThe consumables segment is estimated to account for the largest market share in 2019.
The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.In the toxicity endpoints and tests market, the organ toxicity segment is expected to grow at the highest CAGR during the forecast periodThe organ toxicity segment is expected to grow at the highest CAGR during the forecast period.
The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing marketThe cell culture technologies segment is estimated to account for the largest market share in 2018.
The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast periodThe APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period.
Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety are some of the key factors driving the growth of the market in the APAC.Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: [email protected]
